Insider trades

Quang X. Pham, Chairman of Cadrenal Therapeutics CVKD, has filed 7 purchases and 32 sales on the open market. Over the past 12 months that comes to a net sale of $457.9K. The latest trade was on 06/26.

Quang X. Pham

Chairman, CEO and Interim CFO
First filing
23/02/13
Trades
45 trades
Buys / sales
7 / 32
12-month net buying
−$457.9K
Last trade
06/26

Trading activity

Transactions

Trade type
CVKD
Open-market sale10b5-1 plan06/25–06/2606/2611,156 sh2 trades$3.04avg.$33,919.45−9.5%
CVKD
Open-market sale10b5-1 plan06/22–06/2306/2411,444 sh2 trades$3.48avg.$39,829.25−8.9%
CVKD
Open-market sale10b5-1 plan06/16–06/1706/184,126 sh2 trades$3.18avg.$13,110.42−3.1%
CVKD
Open-market sale06/11–06/1506/1518,124 sh3 trades$3.88avg.$70,351.96−12.0%
CVKD
Open-market sale10b5-1 plan06/08–06/1006/1022,385 sh3 trades$4.17avg.$93,293.86−12.9%
CVKD
Open-market sale10b5-1 plan06/03–06/0506/058,285 sh3 trades$4.37avg.$36,209.04−4.6%
CVKD
Open-market sale10b5-1 plan05/29–06/0206/02652 sh2 trades$4.72avg.$3,074.57−0.4%
CVKD
Open-market sale10b5-1 plan05/11–05/2805/2912,763 sh3 trades$5.44avg.$69,450.97−6.5%
Open-market sale10b5-1 plan05/2205/261,165 sh$5.69$6,628.85−0.6%
CVKD
Open-market sale10b5-1 plan25/10/24–25/10/2725/10/282,444 sh2 trades$14.01avg.$34,236.72−1.2%
CVKD
Open-market sale10b5-1 plan25/10/09–25/10/1325/10/143,600 sh2 trades$14.09avg.$50,706−1.8%
Open-market sale10b5-1 plan25/10/0225/10/03500 sh$14.13$7,065−0.2%
CVKD
Open-market sale10b5-1 plan25/09/29–25/10/0125/10/011,300 sh2 trades$14.01avg.$18,213−0.6%
CVKD
Open-market sale10b5-1 plan25/09/24–25/09/2525/09/269,371 sh2 trades$14.06avg.$131,779.29−4.4%
CVKD
Open-market sale10b5-1 plan25/08/27–25/08/2825/08/295,029 sh2 trades$13.99avg.$70,355.71−2.3%
CVKD
Open-market buy23/09/0523/09/0640,000 sh2 trades$0.91avg.$36,200+1.2%
CVKD
Open-market buy23/09/0123/09/0570,000 sh5 trades$0.91avg.$63,900+2.1%